Parkinson's Disease Trial, Recruiting NCT06052280 Sponsor: Azienda Sanitaria Locale CN1 Cuneo Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06052280
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older
  • People who have been medically diagnosed with idiopathic Parkinson's disease (Parkinson's with no known external cause) according to the most recent specialist diagnostic guidelines
  • People whose Parkinson's disease is at an early-to-moderate stage, rated 2 or below on a standard scale used to measure how far the condition has progressed (Hoehn & Yahr scale)
  • People who score above 25 on a standard memory and thinking assessment (Montreal Cognitive Assessment), indicating no significant cognitive impairment
  • People who are able to read, understand, and sign a written consent form
  • People who are willing and able to attend scheduled check-ins and follow the study procedures throughout the trial

Additional requirements for people in the telerehabilitation (home-based exercise technology) group:

  • Access to wireless internet at home
  • Enough space at home to set up the telerehabilitation device, roughly 2 metres in front of its screen

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under 18 years of age
  • People whose Parkinson's-like symptoms are caused by medication, another medical condition, or are classified as an atypical form of Parkinsonism rather than idiopathic Parkinson's disease
  • People whose Parkinson's disease is rated above stage 2 on the Hoehn & Yahr scale, indicating a more advanced stage of the condition
  • People with serious orthopaedic (bone or joint), vascular (circulation), respiratory (breathing), or heart problems, or any other health condition that the lead investigator considers would make it unsafe or difficult to take part in moderate exercise or follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elona Brahimi, MD, Neurology Unit, Movement Disorders Clinic , Local Health Authority, ASL Cuneo 1, Italy

Phone: +390174676121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Sanitaria Locale CN1 Cuneo
Registry
ClinicalTrials.gov
Start date
9 October 2023
Est. completion
1 October 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Study recruitment potentials; Single arm recruitment potentials; Adherence to study path; Compliance to interventions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov